It is a pharma private limited company based in Gandhinahar, Gujarat, India, established in 1996.
1996 | Gandhinahar, Gujarat, India | ActiveRomano Drugs Private Limited, a active private limited company, was established on 06 September 1996 in Gandhinahar, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24231GJ1996PTC030650. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.22 M.
It upholds a compliant status. Its leadership includes Avinash Tukaram Sanas (Director), Rai Adarsh Danesh (Additional Director). Past directors included Swati Shrikant Deshpande, Shrikant Shankarrao Deshpande, Mohit Chhajed. It holds ₹1.57 Cr open charges and ₹2.60 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 9/B Trimul Estate, Nr. Lincoin Pharma Po.: Khatraj, Ta. Kalol, Gandhinahar, Gujarat, 382721.
U24231GJ1996PTC030650
030650
06 September 1996
₹2.50 M
₹2.22 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Romano Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Avinash Tukaram Sanas | Director | 05 Feb 2024 | Current |
| Rai Adarsh Danesh | Additional Director | 03 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2009 | Past |
| Pramod Abcsdd | Director | 21 Jul 2025 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 09 Jun 2023 | Past |
| Pramod Abcsdd | Director | 23 Sep 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Romano Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.23% increase. The company also saw a slight decrease in profitability, with a 9.81% decrease in profit. The company's net worth Soared by an impressive increase of 230.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Romano Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹15,700,000.00
₹26,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2023 | Others | ₹1.57 Cr | Satisfied |
| 07 Aug 2012 | Punjab National Bank | ₹8.00 M | Satisfied |
| 17 Nov 1998 | Gujarat State Financial Corporation | ₹2.30 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Romano Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Romano Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Romano Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 30 Sep 2023 via Charge ID 100794557 with Others was fully satisfied on 30 Aug 2025. was recorded as a recent event.
The activity Rai Adarsh Danesh was appointed as a Additional Director was appointed as a Additional Director on 03 Jul 2025 & has been associated with this company since 5 months 1 day . was completed.
Romano Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Romano Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Avinash Tukaram Sanas was appointed as a Director was appointed as a Director on 05 Feb 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
The activity A charge with Others amounted to Rs. 15.70 M with Charge ID 100794557 was registered on 30 Sep 2023. was completed.
The CIN of Romano Drugs Private Limited is U24231GJ1996PTC030650.
Romano Drugs Private Limited is headquartered at 9/B Trimul Estate, Nr. Lincoin Pharma Po.: Khatraj, Ta. Kalol, Gandhinahar, Gujarat, 382721.
Romano Drugs Private Limited was incorporated on 06 September 1996.
The current directors of Romano Drugs Private Limited are
The primary industry of Romano Drugs Private Limited is Manufacturing.
Romano Drugs Private Limited is unlisted.
The authorized capital of Romano Drugs Private Limited is ₹2.50 M, and the paid-up capital is ₹2.22 M.
The compliance status of Romano Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX